| HOME >> BIOLOGY >> TECHNOLOGY |
Classification of Bladder Cancer II-35
Non-Invasive Cancer II-35
Invasive Cancer II-35
Types of Bladder Cancer II-36
Transitional Cell Carcinoma/Urothelial Carcinoma II-36
Squamous Cell Carcinoma II-36
Adenocarcinoma II-36
Table 9: US Prevalence of Bladder Cancer by Type (includes
corresponding Graph/Chart) II-36
Major Risk Factors II-37
Controllable Risk Factors II-37
Uncontrollable Risk Factors II-37
Symptoms and Diagnosis II-38
Symptoms II-38
Diagnosis II-38
General Diagnostic Tests II-39
Blood Tests II-39
Physical Examination II-39
Urine Test II-39
Prescribed Procedure to Locate Bladder Cancer II-39
Cytoscopy and Biopsy II-39
Intravenous Pyelogram (IVP) II-39
Ultrasound Scanning II-39
Test/Procedures to Confirm Cancer Penetration II-40
CT Scan II-40
Radioisotope Bone Scan II-40
Staging and Grading of Bladder Cancer: Crucial for Treatment II-40
Staging II-40
Grading II-41
6. RESEARCH & DEVELOPMENT II-42
Variations in PSCA Gene Increase Risk of Bladder Cancer II-42
Genetic Analysis for Assaying Bladder Cancer Recurrence II-42
Selenium Allays the Risk of Bladder Cancer II-43
Individuals with Common Genome Variants at Increased Risk of
Developing Bladder Cancer II-43
New Studies Reveal Correlation Between Coffee and Bladder Cancer II-43
Raw Cruciferous Vegetables Alleviates the Risk of Bladder Cancer II-44
Broccoli Sprouts a Super-Food to Prevent Bladder Cancer II-44
Well Water Counts to the Risk Factors for the Bladder cancer II-44
Frankincense Oil: Potentially a Future Aid for Bladder Cancer II-44
SRC Gene Suppresses Bladder Cancer Metastases II-45
7. FDA APPROVALS AND FILINGS II-46
Allos Therapeutics Obtains FDA Orphan Drug Designation fo
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |